You have not verified your Email yet. Please verify your Email to create alerts
Verify Email
DR.AGAR.EYE
|
Dr Agarwals Eye Hsp
|
Indoco Remedies
|
FDC
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
22.26 % | 9.23 % | 13.1 % |
|
5yr average Equity Multiplier
|
3.33 | 1.77 | 1.55 |
|
5yr Average Asset Turnover Ratio
|
0.91 | 0.91 | 0.52 |
|
5yr Avg Net Profit Margin
|
7.9 % | 5.59 % | 16.21 % |
|
Price to Book
|
11.4 | 2.83 | 3.72 |
|
P/E
|
33.05 | 29.75 | 25.3 |
|
5yr Avg Cash Conversion Cycle
|
-299.77 Days | 50.62 Days | -4.62 Days |
|
Inventory Days
|
13.0 Days | 67.15 Days | 57.02 Days |
|
Days Receivable
|
12.79 Days | 70.89 Days | 20.32 Days |
|
Days Payable
|
262.12 Days | 140.07 Days | 84.76 Days |
|
5yr Average Interest Coverage Ratio
|
4.72 | 7.2 | 106.56 |
|
5yr Avg ROCE
|
18.73 % | 13.14 % | 14.86 % |
|
5yr Avg Operating Profit Margin
|
25.71 % | 15.39 % | 24.57 % |
|
5 yr average Debt to Equity
|
0.41 | 0.35 | 0.0 |
|
5yr CAGR Net Profit
|
25.37 % | n/a | 2.71 % |
|
5yr Average Return on Assets
|
6.65 % | 5.36 % | 8.46 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
71.9 % | 58.72 % | 69.66 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.12 % | 0.03 % | 0.31 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -0.83 % | 2.95 % |
|
Dr Agarwals Eye Hsp
|
Indoco Remedies
|
FDC
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
